Search

Digital Diabetes Management Market

Digital Diabetes Management Market Trends, Opportunity, and Forecast Analysis, 2024-2033

Digital Diabetes Management market revenue to generate USD 61.1 Billion by 2033, according to KDMI analyst’s growth analysis. The market is segmented by product, by type, by end-user, by component, and by Region.


Digital Diabetes Management Market Size Survey Report – In a Glance

As per the survey report on global Digital Diabetes Management market, the market is projected to foresee a CAGR of CAGR value 13.5% between 2024-2033, and further generate a market size of USD 61.1 billion revenue by the end of 2033. In the year 2024, the market size was valued at USD 19.2 billion revenue.

  • The global Digital Diabetes Management market is projected to grow on account of the rising prevalence of diabetes.
  • In Japan, the Digital Diabetes Management market growth can be attributed to the replacement of traditional Japanese diet by western dietary pattern.
  • KDMI analyst’s growth analysis foresees data privacy and security concerns to challenge the market growth.
  • North America, having the highest market share in the Digital Diabetes Management market, is projected to dominate the global market.

Digital Diabetes Management Market Analysis

Nowadays, diabetes can be tracked and managed effectively with the help of technology and digital tools like apps, digital devices, health metrics, and various tracking platforms, helping patients, especially by tracking blood glucose levels and providing other wellness benefits. In recent times, the rapid surge in diabetes patients globally is boosting the Digital Diabetes Management market during the forecasted period. As per the 2021 reports of the International Diabetes Federation, 10.5% of the adult demographic (20-79 years) has diabetes, and half of the population is completely clueless and unaware that they are living with the illness. F. Hoffmann-La Roche Ltd., Bayer AG, Lifescan, Inc., are some of the significant parties in the global market for Digital Diabetes Management.


Analyst’s Observation on Japan Digital Diabetes Management Market Survey

In Japan, the market growth for Digital Diabetes Management can be attributed to the replacement of traditional Japanese diet by western dietary pattern. The traditional Japanese diet transformed significantly it used to consist of a diet lower in consumption of fatty acids, and higher in consumption of rice, soy-derived proteins, fish, and green tea but now the consumption of high-calorie foods like milk, meat, poultry, and eggs and fat has increased, while that of barley, potatoes, and rice has decreased, leading to obesity and diabetes. More than three-quarters of people are living with diabetes, and the proportion is bound to increase as global prevalence rises from an estimated 537 million adults today to a predicted 643 million by 2030, increasing the coverage by more than four million patients to a total of 40.5 million last year. Chugai Pharmaceutical Co. Ltd., Bayer Holding Ltd., Braun Aesculap Japan Co. Ltd., are some of the significant parties in the market for Digital Diabetes Management in Japan.

Digital Diabetes Management Market: Report Scope

Base Year

     2023

Estimated Market Size

    USD 19.2 Billion in 2024

Forecast Year

     2024-2033

Projected Market Size

     USD 61.1 Billion in 2033

CAGR Value

    13.5%

Digital Diabetes Management Market Key Trends/Major Growth Drivers

  • Increasing technological advancements
  • Focus on preventive healthcare
  • Replacement of traditional Japanese diet by western dietary pattern

Restraint Factors

  • Data privacy and security concerns
  • Regulatory hurdles

Digital Diabetes Management Market Segmentation

  • By Product
  • By Type
  • By End-user
  • By Component
  • By Geography

Digital Diabetes Management Market Key Players

Abbott Laboratories, Medtronic PLC, F. Hoffmann-La Roche Ltd., and others.


Digital Diabetes Management Market Growth Driver and Challenges

Growth Driver

Increasing technological advancements:

The technological advancements and innovations in sensors, mobile technology and data analytics are noticeably bettering digital diabetes management tools, making them more simple to navigate, and efficient for both patients and healthcare providers across the world, fuelling the digital diabetes management market. Digital diabetes tools are altering the scenario of diabetes care and treatment with a seamless ecosystem for real-time health monitoring, including blood glucose levels, physical activity, medication compliance, enabling remote monitoring and personalized interventions. Artificial intelligence is also booming nowadays in the healthcare sector and according to reports, there will be a rapid surge in adaptive and generative AI which is expected to exceed $500 billion in 2023.

Restraint

Data privacy and security concerns:

Data privacy and cybersecurity concerns can hinder the growth of the diabetes digital management market on the global level and sensitive health information is transmitted and stored digitally. Furthermore, technical issues, such as device compatibility problems and inaccurate readings can also break down the trust of the users. As per findings, more than 5000 cybercrime complaints are lodged daily, which further leads to uncertainties regarding product safety and effectiveness, restricting the market growth.


Digital Diabetes Management Market Segmentation

Our experts at KD Market Insights have segmented the global Digital Diabetes Management market research report as:

By Product

  • Smart Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Smart Insulin Pens
  • Smart Insulin Pumps
  • Others

By Type

  • Wearable Devices
  • Handheld Devices

By End-user

  • Hospitals & Specialty Clinics
  • Home Care Settings
  • Academic & Research Institutes

By Component

  • Devices
  • Apps & Software
  • Services

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Indonesia
    • Malaysia
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa

Digital Diabetes Management Market Regional Synopsis

The North America having the highest market share in Digital Diabetes Management market and is majorly driven by due to its progressive healthcare framework, widespread acceptance of technology, and rigorous research and growth initiatives. Moreover, expanding diabetic population is also a contributing factor in the acceleration of digital diabetes management market growth.

Asia Pacific region is foreseen for rapid development in the digital diabetes management market due to several factors and the region holds a considerable diabetic population, surging the demand for advanced management solutions. Rapid technological acceptance, fuelled by a surge in smart phone usage and internet penetration, promotes digital health integration.

As per our analysts at KD Market Insights, the following five players lead the North America Digital Diabetes Management market growth:

  • Medtronic
  • Dexcom
  • Abbott Laboratories
  • Insulet Corporation
  • Livongo Health

Digital Diabetes Management Market Competitive Landscape

Some of the key players who top the global Digital Diabetes Management market share:

  • Abbott Laboratories
  • Medtronic PLC
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • Lifescan, Inc.
  • Dexcom, Inc.
  • Sanofi
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • B Braun Melsungen AG

  1. Executive Summary
    1. Market Overview
    2. Key Findings
    3. Market Trends
    4. Market Outlook
  2. Introduction
    1. Scope of the Report
    2. Research Methodology
    3. Definitions and Assumptions
    4. Acronyms and Abbreviations
  3. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Challenges
  4. Global Digital Diabetes Management  Market
    1. Market Overview
    2. Market Size and Forecast
    3. Market Segmentation
      1. By Product
      2. By Type
      3. By End-user
      4. By Component
      5. By Region
  5. Market Segmentation by Product
      1. Smart Glucose Meters
      2. Continuous Glucose Monitoring Systems
      3. Smart Insulin Pens
      4. Smart Insulin Pumps
      5. Others
  6. Market Segmentation by Type
      1. Wearable Devices
      2. Handheld Devices
  7. Market Segmentation by End-user
      1. Hospitals & Specialty Clinics
      2. Home Care Settings
      3. Academic & Research Institutes
  8. Market Segmentation by Component
      1. Devices
      2. Apps & Software
      3. Services
  9. Regional Analysis
    1. North America
      1. United States
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      2. Canada
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      3. Mexico
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
    2. Europe
      1. United Kingdom
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      2. Germany
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      3. France
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      4. Italy
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      5. Spain
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      6. Rest of Europe
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
    3. Asia Pacific
      1. China
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      2. Japan
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      3. India
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      4. Australia
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
        4. South Korea
        5. Market Size and Forecast
        6. Key Trends and Developments
        7. Market Analysis by Product, Type, End-user, and Component
      5. Rest of Asia Pacific
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
    4. Latin America
      1. Brazil
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      2. Argentina
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      3. Colombia
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      4. Rest of Latin America
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
    5. Middle East & Africa
      1. South Africa
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      2. Saudi Arabia
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      3. UAE
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
      4. Rest of Middle East & Africa
        1. Market Size and Forecast
        2. Key Trends and Developments
        3. Market Analysis by Product, Type, End-user, and Component
  10. Competitive Landscape
    1. Market Share Analysis
    2. Company Profiles
    3. Medtronic (Ireland)
    4. IBM
    5. Apple Inc.
    6. Siemens Medical Solutions
    7. Pepperl+Fuchs
    8. Cisco
    9. GE Healthcare
  11. Strategic Recommendations
  12. Appendix
    1. List of Tables
    2. List of Figures
  13. References

Need Customized Report for Your Business ?

Utilize the Power of Customized Research Aligned with Your Business Goals

Request for Customized Report
Get 10% discount on any market research report of your choice.
Booklet
  • Publication date: February 2025
  • Base year: 2023
  • Forecast year: 2024-2033
  • Format: PDF, PPT,Word,Excel

- ISO Certified Logo -


Frequently Asked Questions(FAQ)

The global Digital Diabetes Management market is expected to cross a value of USD 61.1 billion revenue by the end of 2033.

The global Digital Diabetes Management market was valued at USD 19.2 billion revenue in 2024.

Over the mid-term, the rising prevalence of diabetes is the primary factor anticipated to drive the global Digital Diabetes Management market.

The global Digital Diabetes Management market is segmented by product, by type, by end-user, by component, and by geography.

The North America Digital Diabetes Management market is projected to dominate the global market in 2033.

Some of the key players in the Digital Diabetes Management market include F. Hoffmann-La Roche Ltd., Bayer AG, Lifescan Inc., Insulet Corporation, Ascensia Diabetes Care Holdings AG, and B Braun Melsungen AG, among others.

-: Our Clients :-

Subscribe to Our Company Updates

* We will not share your personal information with anyone
Go Up